Active	Status	Sponsor type	Region	Phase	Filter
2 Active 8 Inactive 10 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Dorman, Susan E
NCT01846663: Efficacy, Safety, And Pharmacokinetics Of Rifaximin In Subjects With Severe Hepatic Impairment And Hepatic Encephalopathy	Terminated	4	6	US	Placebo, Rifaximin, XIFAXAN® Tablets	Bausch Health Americas, Inc.	Hepatic Encephalopathy	02/16	02/16
CRUSH-TB, NCT05766267: Short-course Regimens for the Treatment of Pulmonary Tuberculosis	Recruiting	2/3	288	Canada, US, RoW	Rifabutin, Delamanid, Deltyba, Bedaquiline, Sirturo, Moxifloxacin, Pyrazinamide, Isoniazid, Rifampin, Ethambutol	Centers for Disease Control and Prevention, Tuberculosis Trials Consortium	Tuberculosis, Pulmonary, Tuberculosis Infection	10/25	12/26